Overview
Ryosuke Ando practices in Tokyo, Japan. Mr. Ando is highly rated in 9 conditions, according to our data. His top areas of expertise are Kidney Stones, Urothelial Cancer, Bladder Cancer, Lithotripsy, and Ureteroscopy.
His clinical research consists of co-authoring 165 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Kidney StonesMr. Ando isElite. Learn about Kidney Stones.
- Distinguished
- LithotripsyMr. Ando isDistinguished. Learn about Lithotripsy.
- Advanced
- Bladder CancerMr. Ando isAdvanced. Learn about Bladder Cancer.
- EndoscopyMr. Ando isAdvanced. Learn about Endoscopy.
- Metabolic SyndromeMr. Ando isAdvanced. Learn about Metabolic Syndrome.
- Postmenopausal OsteoporosisMr. Ando isAdvanced. Learn about Postmenopausal Osteoporosis.
- Prostate CancerMr. Ando isAdvanced. Learn about Prostate Cancer.
- UreteroscopyMr. Ando isAdvanced. Learn about Ureteroscopy.
- Experienced
- Abdominal Obesity Metabolic Syndrome
- AgranulocytosisMr. Ando isExperienced. Learn about Agranulocytosis.
- Cerebral HypoxiaMr. Ando isExperienced. Learn about Cerebral Hypoxia.
- CystectomyMr. Ando isExperienced. Learn about Cystectomy.
- HydronephrosisMr. Ando isExperienced. Learn about Hydronephrosis.
- Inflammatory Myofibroblastic TumorMr. Ando isExperienced. Learn about Inflammatory Myofibroblastic Tumor.